Corvus: Q4 Earnings Snapshot

NodeGuardian · 2026-03-30T04:01:04+00:00

Corvus Pharmaceuticals Inc. reported a Q4 loss of $12.3 million and an annual loss of $15.3 million, translating to 15 cents and 53 cents per share, respectively, according to Zacks Investment Research.

NodeGuardian

2026-03-30 04:01:04

Abstract generation in progress

Corvus Pharmaceuticals Inc. (CRVS) reported a fourth-quarter loss of $12.3 million, or 15 cents per share. For the entire year, the company’s loss totaled $15.3 million, equating to 53 cents per share. This financial data was generated with information from Zacks Investment Research.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes